Skip to main content
Premium Trial:

Request an Annual Quote

Pangea, Molecular Simulations Integrate Bioinformatics Tools


OAKLAND, Calif.--Two bioinformatics software providers--Pangea Systems here and Molecular Simulations of San Diego, Calif.--have agreed to integrate certain elements of their respective product lines to enhance both bioinformatics packages. The companies will use Pangea's application programming interface to link the company's data management system with Molecular Simulations' WebLab Gene Explorer application. Gene Explorer is a graphical environment for analyzing and viewing DNA and protein sequences and structures.

According to the companies, the collaboration will give Gene Explorer users a single point of access to five major public databases and any proprietary data they add to their systems. This should accelerate the drug discovery process, they predicted. In addition, the two firms will investigate establishing links between Pangea's data management system and Molecular Simulations' line of chemical and structural analysis applications for drug discovery.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.